These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 27214088)
1. Acute eprosartan-induced intrarenal vasodilation in hypertensive humans is not influenced by dietary sodium intake or angiotensin II co-infusion. van Twist DJ; Houben AJ; de Leeuw PW; Kroon AA J Hypertens; 2016 Aug; 34(8):1607-14. PubMed ID: 27214088 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin-(1-7)-induced renal vasodilation in hypertensive humans is attenuated by low sodium intake and angiotensin II co-infusion. van Twist DJ; Houben AJ; de Haan MW; Mostard GJ; Kroon AA; de Leeuw PW Hypertension; 2013 Oct; 62(4):789-93. PubMed ID: 23918750 [TBL] [Abstract][Full Text] [Related]
3. Effect of angiotensin II antagonist eprosartan on hyperglycemia-induced activation of intrarenal renin-angiotensin system in healthy humans. Osei SY; Price DA; Laffel LM; Lansang MC; Hollenberg NK Hypertension; 2000 Jul; 36(1):122-6. PubMed ID: 10904023 [TBL] [Abstract][Full Text] [Related]
4. Intrarenal Mas and AT O'Neill J; Healy V; Johns EJ Exp Physiol; 2017 Dec; 102(12):1700-1715. PubMed ID: 28940861 [TBL] [Abstract][Full Text] [Related]
5. Renal hemodynamic response to an angiotensin II antagonist, eprosartan, in healthy men. Price DA; De'Oliveira JM; Fisher ND; Hollenberg NK Hypertension; 1997 Aug; 30(2 Pt 1):240-6. PubMed ID: 9260987 [TBL] [Abstract][Full Text] [Related]
6. A dose-response study to assess the renal hemodynamic, vascular, and hormonal effects of eprosartan, an angiotensin II AT1-receptor antagonist, in sodium-replete healthy men. Ilson BE; Boike SC; Martin DE; Freed MI; Zariffa N; Jorkasky DK Clin Pharmacol Ther; 1998 Apr; 63(4):471-81. PubMed ID: 9585802 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin-(1-7)-induced renal vasodilation is reduced in human kidneys with renal artery stenosis. Van Twist DJ; Houben AJ; De Haan MW; Mostard GJ; De Leeuw PW; Kroon AA J Hypertens; 2014 Dec; 32(12):2428-32; discussion 2432. PubMed ID: 25208127 [TBL] [Abstract][Full Text] [Related]
8. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet. Ruan X; Wagner C; Chatziantoniou C; Kurtz A; Arendshorst WJ J Clin Invest; 1997 Mar; 99(5):1072-81. PubMed ID: 9062366 [TBL] [Abstract][Full Text] [Related]
9. Impaired neuronal and vascular responses to angiotensin II in a rabbit congestive heart failure model. Nap A; Belterman CN; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):220-7. PubMed ID: 14689369 [TBL] [Abstract][Full Text] [Related]
10. Eprosartan modulates the reflex activation of the sympathetic nervous system in sodium restricted healthy humans. Vase H; Lauridsen TG; Bech JN; Pedersen EB Br J Clin Pharmacol; 2008 Jun; 65(6):822-32. PubMed ID: 18341678 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin blockade with eprosartan: vascular and functional implications. Ram CV Curr Med Res Opin; 2007 Nov; 23 Suppl 5():S5-11. PubMed ID: 18093408 [TBL] [Abstract][Full Text] [Related]
12. Renal hemodynamics and renin-angiotensin system activity in humans with multifocal renal artery fibromuscular dysplasia. van Twist DJ; Houben AJ; de Haan MW; de Leeuw PW; Kroon AA J Hypertens; 2016 Jun; 34(6):1160-9. PubMed ID: 27032075 [TBL] [Abstract][Full Text] [Related]
13. Prejunctional and postjunctional inhibitory actions of eprosartan and candesartan in the isolated rabbit mesenteric artery. Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA J Cardiovasc Pharmacol; 2002 Jul; 40(1):50-7. PubMed ID: 12072577 [TBL] [Abstract][Full Text] [Related]
14. The effect of eprosartan on reflex sympathetic activation in sodium restricted patients with essential hypertension. Vase H; Lauridsen TG; Graffe CC; Pedersen EB J Am Soc Hypertens; 2011; 5(5):385-94. PubMed ID: 21640689 [TBL] [Abstract][Full Text] [Related]
15. Adrenal angiotensin: origin and site of generation. van Kats JP; Chai W; Duncker DJ; Schalekamp MA; Danser AH Am J Hypertens; 2005 Aug; 18(8):1104-10. PubMed ID: 16109325 [TBL] [Abstract][Full Text] [Related]
16. Intrarenal infusion of angiotensin-(1-7) modulates renal functional responses to exogenous angiotensin II in the rat. Bürgelová M; Kramer HJ; Teplan V; Velicková G; Vítko S; Heller J; Malý J; Cervenka L Kidney Blood Press Res; 2002; 25(4):202-10. PubMed ID: 12424421 [TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic study of eprosartan mesylate-loaded transfersomes Carbopol Ahad A; Al-Saleh AA; Al-Mohizea AM; Al-Jenoobi FI; Raish M; Yassin AEB; Alam MA Biomed Pharmacother; 2017 May; 89():177-184. PubMed ID: 28237913 [TBL] [Abstract][Full Text] [Related]
18. Failure of angiotensin II to suppress plasma renin activity in normotensive subjects with a positive family history of hypertension. Herlitz H; Palmgren E; Widgren B; Aurell M Clin Sci (Lond); 2005 Sep; 109(3):311-7. PubMed ID: 15901242 [TBL] [Abstract][Full Text] [Related]
19. Effects of eprosartan on renal function and cardiac hypertrophy in rats with experimental heart failure. Brodsky S; Gurbanov K; Abassi Z; Hoffman A; Ruffolo RR; Feuerstein GZ; Winaver J Hypertension; 1998 Oct; 32(4):746-52. PubMed ID: 9774374 [TBL] [Abstract][Full Text] [Related]
20. The effects of eprosartan, an angiotensin II AT1 receptor antagonist, on uric acid excretion in patients with mild to moderate essential hypertension. Ilson BE; Martin DE; Boike SC; Jorkasky DK J Clin Pharmacol; 1998 May; 38(5):437-41. PubMed ID: 9602957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]